CLINICAL_TRIALS ClinicalTrials.gov record update

Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT04620239
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-07-22T00:00:54.165288+00:00
Published At: 2026-07-21T00:00:00+00:00
Record Updated At: 2026-07-21
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Transitional Cell Cancer of Renal Pelvis and Ureter"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2026-07-21"
protocolSection.identificationModule.nctId: "NCT04620239"
protocolSection.identificationModule.officialTitle: "Multicenter Phase 3 Pivotal Study to Evaluate the Safety and Efficacy of TOOKAD (Padeliporfin) Vascular Targeted Photodynamic Therapy in the Treatment of Low Grade Upper Tract Urothelial Cancer"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: ""

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.